Blog
The case for patient-controlled rare disease data across science, policy, and the lived experience.
Featured
Patient Experience
What we still have to do
The structural friction of rare disease daily life.
Read →This week
Search articles
Browse by tag
Clear ×Read all10 of 116 · Tag: Ultra-rare
- May 7, 2026Ethan Perlstein and the other n-of-1
- May 7, 2026Adrian Krainer and the splicing mechanism that became Spinraza
- May 7, 2026Wendy Chung and the natural-history-first model
- May 7, 2026Steven Gray and the AAV9 platform for rare brain disease
- May 7, 2026Stanley Crooke and the n-of-many foundation
- May 7, 2026Timothy Yu and the lab that built the first individualized drug
- May 7, 2026AAV gene therapy at single-patient scale
- May 7, 2026How splice-switching ASOs work
- May 7, 2026What an n-of-1 trial actually is
- Apr 28, 2026The network, and why it exists